Trial Outcomes & Findings for Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure (NCT NCT01472692)

NCT ID: NCT01472692

Last Updated: 2019-12-16

Results Overview

• Recruitment status: COMPLETED
• Study phase: PHASE4
• Target enrollment: 47 participants
• Primary outcome timeframe: 8 weeks
• Results posted on: 2019-12-16

Participant Flow

The Principal Investigator for this study has passed away and the results data is not available.

Participant milestones

Measure	Febuxostat Febuxostat: 80mg PO daily for 8 weeks	Placebo Febuxostat: 80mg PO daily for 8 weeks
Overall Study STARTED	0	0
Overall Study COMPLETED	0	0
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: 8 weeks

Population: The Principal Investigator for this study has passed away and the results data is not available.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 8 weeks

Population: The Principal Investigator for this study has passed away and the results data is not available.

Outcome measures

Outcome data not reported

Adverse Events

Febuxostat

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Placebo

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Department of Medicine

UCSD

Phone: (858) 552-8585

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place